Central venous access devices in patients with hemophilia

References

• Mannucci PM, Tuddenham EG. The hemophilias – from royal genes to gene therapy. N. Engl. J. Med. 344, 1773–1779 (2001).
   PubMed Web of Science ®Google Scholar
• Ewenstein BM, Valentino LA, Journeycake JM et al. Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia 10, 629–648 (2004).
   PubMed Web of Science ®Google Scholar
• Larson E. Status of practice guidelines in the United States: CDC guidelines as an example. Prev. Med. 36, 519–524 (2003).
   Google Scholar
• Galloway S, Bodenham A. Long-term central venous access. Br. J. Anaesth. 92, 722–734 (2004).
   PubMed Web of Science ®Google Scholar
• Hamilton H. Central venous catheters: choosing the most appropriate access route. Br. J. Nurs. 13, 862–870 (2004).
   Google Scholar
• Ljung R. Central venous catheters in children with haemophilia. Blood Rev. 18, 93–100 (2004).
   Google Scholar
• Ljung R. Central venous lines in haemophilia. Haemophilia 9(Suppl. 1), 88–92 (2003).
   PubMed Web of Science ®Google Scholar
• Wight J, Paisley S, Knight C. Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review. Haemophilia 9, 436–463 (2003).
   PubMed Web of Science ®Google Scholar
• Carlborg E, Astermark J, Lethagen S, Ljung R, Berntorp E. The Malmo model for immune tolerance induction: impact of previous treatment on outcome. Haemophilia 6, 639–642 (2000).
   PubMed Web of Science ®Google Scholar
• Hay CR. Hemophilia treatment. Immune tolerance induction: prospective clinical trials. Haematologica 85, 52–55 (2000).
   PubMedGoogle Scholar
• Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of Factor VIII inhibitors – twenty years’ ‘bonn protocol’. Vox Sang. 70(Suppl. 1), 30–35 (1996).
   PubMed Web of Science ®Google Scholar
• Teitel JM, Barnard D, Israels S, Lillicrap D, Poon MC, Sek J. Home management of haemophilia. Haemophilia 10, 118–133 (2004).
   PubMed Web of Science ®Google Scholar
• Ross-Degnan D, Soumerai SB, Avorn J, Bohn RL, Bright R, Aledort LM. Hemophilia home treatment. Economic analysis and implications for health policy. Int. J. Technol. Assess. Health Care 11, 327–344 (1995).
   Google Scholar
• Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Haemophilia 10, 134–146 (2004).
   PubMed Web of Science ®Google Scholar
• Allain JP. A boarding school for hemophiliacs: a model for the comprehensive care of hemophilic children. Ann. NY Acad. Sci. 240, 226–237 (1975).
   Google Scholar
• Inwood MJ. Aids for hemophiliac children on a self-infusion program. J. Pediatr. 92, 78–79 (1978).
   Google Scholar
• Markova I, Forbes CD, Rowlands A, Pettigrew A, Willoughby M. The haemophilic patient’s self-perception of changes in health and life-style arising from self-treatment. Int. J. Rehabil. Res. 6, 11–18 (1983).
   PubMedGoogle Scholar
• Schimpf K. The role of self-infusion treatment for the patient with haemophilia (author’s transl). Blut 36, 63–71 (1978).
   Google Scholar
• O’Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disese Control and Prevention, US Pediatrics. 110, E51 (2002).
   Google Scholar
• Fijnheer R, Paijmans B, Verdonck LF, Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter-associated thrombosis. Br. J. Haematol. 118, 267–270 (2002).
   Google Scholar
• Decker MD, Edwards KM. Central venous catheter infections. Pediatr. Clin. North Am. 35, 579–612 (1988).
   PubMed Web of Science ®Google Scholar
• Essex-Cater A, Gilbert J, Robinson T, Littlewood JM. Totally implantable venous access systems in paediatric practice. Arch. Dis. Child 64, 119–123 (1989).
   PubMedGoogle Scholar
• Girvan DP, deVeber LL, Inwood MJ, Clegg EA. Subcutaneous infusion ports in the pediatric patient with hemophilia. J. Pediatr. Surg. 29, 1220–1223 (1994).
   Google Scholar
• Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol. 17, 438–473 (1996).
   PubMedGoogle Scholar
• Geraghty S, Kleinert D. Use and morbidity of venous access devices in patients with hemophilia. J. Intraven. Nurs. 21, 70–75 (1998).
   Google Scholar
• Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am. J. Pediatr. Hematol. Oncol. 13, 130–136 (1991).
   PubMedGoogle Scholar
• Mirro J Jr, Rao BN, Kumar M et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J. Pediatr. Surg. 25, 120–124 (1990).
   PubMedGoogle Scholar
• Mirro J Jr, Rao BN, Stokes DC et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J. Clin. Oncol. 7, 214–222 (1989).
   PubMedGoogle Scholar
• O’Keefe SJ, Burnes JU, Thompson RL. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. J. Parenter. Enteral Nutr. 18, 256–263 (1994).
   PubMed Web of Science ®Google Scholar
• Pegues D, Axelrod P, McClarren C et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J. Surg. Oncol. 49, 156–162 (1992).
   Google Scholar
• Vora A, Lilleyman, JS. Vascular access in young hemophiliacs: use of indwelling central venous catheters. Int. J. Pediatr. Hematol. Oncol. 1, 521–527 (1994).
   Google Scholar
• Povoski S. Long-term venous access. In: Cancer Management: A Multidisciplinary Approach. Pazdur R, Coia LR, Hoskins WJ, Wagman LD (Eds). SCP Communications, Inc., NY, USA, 897–908 (2003).
   Google Scholar
• Centers for Disease Control and Prevention. Report on the Universal Data Collection Program. 6(2), 17 (2004).
   Google Scholar
• Manco-Johnson M. Hemophilia management: optimizing treatment based on patient needs. Curr. Opin. Pediatr. 17, 3–6 (2005).
   Google Scholar
• MASAC. MASAC Recommendations Regarding Central Venous Access Devices Including Ports and Passports. (2001).
   Google Scholar
• Joshi R, Barrett AJ, Wastell C, Gibberd FB. Use of a Hickman catheter for permanent venous access in a patient with severe haemophilia. Clin. Lab. Haematol. 4, 319–321 (1982).
   Google Scholar
• Tarantino MD, Lail A, Donfield SM et al. Surveillance of infectious complications associated with central venous access devices in children with haemophilia. Haemophilia 9, 588–592 (2003).
   PubMed Web of Science ®Google Scholar
• Scatorchia G. Tunneled catheters. In: Central Venous Catheters. Ray C Jr (Ed.). Lippincott Williams & Wilkins, PA, USA, 73–86 (2001).
   Google Scholar
• Ahmad I. Complications of central venous access devices. In: Central Venous Access. Ray C Jr (Ed.). Lippincott Williams & Wilkins, PA, USA, 151–164 (2001).
   Google Scholar
• Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 101, 4273–4278 (2003).
   PubMed Web of Science ®Google Scholar
• Tisnado J, Pieters, PC. Complications of central venous catheters. In: Venous Catheters: A Practical Manual. Pieters P, Tisnado J, Mauro MA (Eds). Thieme, NY, USA, 249–280 (2003).
   Google Scholar
• Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 6, 66–70 (2000).
   Google Scholar
• Van Den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP. The use of the Port-A-Cath in children with haemophilia – a review. Haemophilia 4, 418–420 (1998).
   Google Scholar
• Blanchette VS, Al-Musa A, Stain AM, Ingram J, Fille RM. Central venous access devices in children with hemophilia: an update. Blood Coagul. Fibrinolysis 8(Suppl. 1), S11–S14 (1997).
   PubMedGoogle Scholar
• Perkins JL, Johnson VA, Osip JM et al. The use of implantable venous access devices (IVADs) in children with hemophilia. J. Pediatr. Hematol. Oncol. 19, 339–344 (1997).
   Google Scholar
• Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone–iodine solution for vascular catheter-site care: a meta-analysis. Ann. Intern. Med. 136, 792–801 (2002).
   PubMed Web of Science ®Google Scholar
• Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone–iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338, 339–343 (1991).
   PubMed Web of Science ®Google Scholar
• O’Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51, 1–29 (2002).
   PubMedGoogle Scholar
• Male C, Chait P, Ginsberg JS et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb. Haemost. 87, 593–598 (2002).
   PubMed Web of Science ®Google Scholar
• Hull J. Tunneled catheters and chest ports. In: Venous Catheters: A Practical manual. Pieters P, Tisnado J, Mauro MA (Eds). Thieme, NY, USA, 97–118 (2003).
   Google Scholar
• Morado M, Jimenez-Yuste V, Villar A et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 7, 551–556 (2001).
   Google Scholar
• Tock B, Drohan W, Hess J, Pusateri A, Holcomb J, Macphee M. Haemophilia and advanced fibrin sealant technologies. Haemophilia 4, 449–455 (1998).
   Google Scholar
• Blanchette VS, al-Musa A, Stain AM, Filler RM, Ingram J. Central venous access catheters in children with haemophilia. Blood Coagul. Fibrinolysis 7(Suppl. 1), S39–S44 (1996).
   PubMed Web of Science ®Google Scholar
• Collins PW, Khair KS, Liesner R, Hann IM. Complications experienced with central venous catheters in children with congenital bleeding disorders. Br. J. Haematol. 99, 206–208 (1997).
   Google Scholar
• Domm JA, Hudson MG, Janco RL. Complications of central venous access devices in paediatric haemophilia patients. Haemophilia 9, 50–56 (2003).
   Google Scholar
• Goldsmith JC, Boody B, Atkinson J. Central venous catheter related complications in children with hemophilia. Blood 872a (1995).
   Google Scholar
• Hothi DK, Kelsall W, Baglin T, Williams DM. Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters. Haemophilia 7, 507–510 (2001).
   PubMed Web of Science ®Google Scholar
• Li CH, Ou Y, Lee AC, So KT. Septic arthritis in hemophilia with central venous catheter: a case report. Pediatr. Hematol. Oncol. 17, 187–189 (2000).
   Web of Science ®Google Scholar
• Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br. J. Haematol. 91, 203–207 (1995).
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Nuss R, Geraghty S, Funk S, Kilcoyne R. Results of secondary prophylaxis in children with severe hemophilia. Am. J. Hematol. 47, 113–117 (1994).
   PubMed Web of Science ®Google Scholar
• McMahon C, Smith J, Khair K, Liesner R, Hann IM, Smith OP. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome. Br. J. Haematol. 110, 461–468 (2000).
   Google Scholar
• Ragni MV, Hord JD, Blatt J. Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate. Haemophilia 3, 90–95 (1997).
   Google Scholar
• Rothschild C, Merckx J, Clairicia M, Dazet D, Torchet MF, Pertuiset N. Experiences with implantable venous access devices in haemophilia children treated intensively: a low rate of complications. Haemophilia 6, 276 (2000).
   Google Scholar
• Santagostino E, Gringeri A, Muca-Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br. J. Haematol. 102, 1224–1228 (1998).
   PubMed Web of Science ®Google Scholar
• Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br. J. Haematol. 104, 461–464 (1999).
   PubMed Web of Science ®Google Scholar
• Warrier I, Baird-Cox K, Lusher JM. Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience. Haemophilia 3, 194–198 (1997).
   PubMed Web of Science ®Google Scholar
• Yee TT, Beeton K, Griffioen A et al. Experience of prophylaxis treatment in children with severe haemophilia. Haemophilia 8, 76–82 (2002).
   PubMed Web of Science ®Google Scholar
• Ljung R, van den Berg M, Petrini P et al. Port-A-Cath usage in children with haemophilia: experience of 53 cases. Acta Paediatr. 87, 1051–1054 (1998).
   PubMed Web of Science ®Google Scholar
• Ljung R, Tengborn L, Petrini P. The Feasbility of long-term venous access in children with hemophilia. Semin. Hematol. 31(Suppl. 2), 16–18 (1994).
   Google Scholar
• Berrington A, Gould FK. Use of antibiotic locks to treat colonized central venous catheters. J. Antimicrob. Chemother. 48, 597–603 (2001).
   PubMed Web of Science ®Google Scholar
• Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. J. Intraven. Nurs. 24, 180–205 (2001).
   PubMedGoogle Scholar
• Ragni M. Infectious and thrombotic complications of central venous catheters in hemophilia patients. Home Healthcare Consultant (1998).
   Google Scholar
• Blanchette VS, Al-Trabolsi H, Stain AM et al. High risk of cental venous line-associated thrombosis in boys with hemophilia. Blood 94, 234a (1999).
   Google Scholar
• Buchanan GR, Miller K, Zajac JL. Upper venous system thrombosis in haemophilia patients with long-term implantable central venous catheters. Haemophilia 6, 271 (2000).
   Google Scholar
• DiMichele DM, Kroner BL. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb. Haemost. 87, 7 (2002).
   Google Scholar
• Ettingshausen CE, Kurnik K, Schobess R et al. Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease. Blood 99, 1499–1500 (2002).
   PubMed Web of Science ®Google Scholar
• Journeycake JM, Buchanan GR. Catheter-related thrombosis in children with hemophilia. Blood 99, 1500 (2002).
   Google Scholar
• Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR. Catheter-related deep venous thrombosis in children with hemophilia. Blood 98, 1727–1731 (2001).
   PubMed Web of Science ®Google Scholar
• Price VE, Carcao M, Connolly B et al. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. J. Thromb. Haemost. 2, 737–742 (2004).
   PubMed Web of Science ®Google Scholar
• Van Dijk K, van Den Berg HM, van der Born JG. Complication of Port-A-Cath (PAC) in children with severe haemophilia. Haemophilia 8, 488 (2002).
   Google Scholar
• Lowell JA Bothe A Jr. Central venous catheter related thrombosis. Surg. Oncol. Clin. N. Am. 4, 479–492 (1995).
   Google Scholar
• Smith JP. Thrombotic complications in intravenous access. J. Intraven. Nurs. 21, 96–100 (1998).
   Google Scholar
• Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr. Opin. Hematol. 10, 369–374 (2003).
   PubMed Web of Science ®Google Scholar
• Brown SA, Aledort LM, Lee CA. Optimal treatment regimens for patients with bleeding disorders. Haemophilia 7, 313–320 (2001).
   Google Scholar
• Medeiros D, Miller KL, Rollins NK, Buchanan GR. Contrast venography in young haemophiliacs with implantable central venous access devices. Haemophilia 4, 10–15 (1998).
   Google Scholar
• Polderman KH, Girbes AR. Central venous catheter use Part 2: infectious complications. Intensive Care Med. 28, 18–28 (2002).
   PubMed Web of Science ®Google Scholar
• Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J. Vasc. Interv. Radiol. 13, 1199–1205 (2002).
   Google Scholar
• Whitman ED. Complications associated with the use of central venous access devices. Curr. Probl. Surg. 33, 309–378 (1996).
   Google Scholar
• Polderman KH, Girbes AR. Central venous catheter use. Part 1: mechanical complications. Intensive Care Med. 28, 1–17 (2002).
   PubMed Web of Science ®Google Scholar
• Pipe SW. The promise and challenges of bioengineered recombinant clotting factors. J. Thromb. Haemost. 3, 1692–1701 (2005).
   PubMed Web of Science ®Google Scholar
• Pipe SW, Saint-Remy JM, Walsh CE. New high-technology products for the treatment of haemophilia. Haemophilia 10(Suppl. 4), 55–63 (2004).
   Google Scholar
• Miekka SI, Jameson T, Singh M et al. Novel delivery systems for coagulation proteins. Haemophilia 4, 436–442 (1998).
   PubMed Web of Science ®Google Scholar
• High K. Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients? J. Thromb. Haemost. 3, 1682–1691 (2005).
   PubMedGoogle Scholar
• High KA. Gene transfer as an approach to treating hemophilia. Semin. Thromb. Hemost. 29, 107–120 (2003).
   PubMed Web of Science ®Google Scholar